|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | Jul-2018 | Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma | Jayamanne, Dasantha ; Back, Michael ; Hayes, A.R.; Hsiao, E.; Schembri, G.; Bailey, D.; Roach, P.J.; Khasraw, M.; Newey, A.; Wheeler, H. |
| 2 | | Feb-2018 | Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI | Jayamanne, Dasantha ; Back, Michael ; Kaushal, Sneha ; Chan, D.L.; Schembri, G.; Brazier, D.; Bailey, D.; Wheeler, H. |
| 3 | | Sep-2018 | Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma | Back, Michael ; Jayamanne, Dasantha ; Rodriguez, M.; Khasraw, M.; Lee, A.; Wheeler, H. |
| 4 | | Nov-2018 | Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma | Back, Michael ; Jayamanne, Dasantha ; Brazier, D.; Bailey, D.; Hsiao, E.; Guo, L.; Wheeler, H. |
| 5 |  | Feb-2016 | Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients | Back, Michael ; Eade, Thomas ; Charles, K.A.; Harris, B.D.; Haddad, C.R.; Clarke, S.J.; Guminksi, A.; Stevens, M.; Dodds, T.; Gill, Anthony J ; Veivers, D. |
| 6 | | Jul-2017 | Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy | Back, Michael ; Jayamanne, Dasantha ; Harris, G.; Wheeler, H.; Gzell, C.; Kastelan, M.; Schembri, G.; Brazier, D.; Cook, R.; Parkinson, J.; Khasraw, M.; Louw, S. |
| 7 | | Mar-2018 | Survival improvements with adjuvant therapy in patients with glioblastoma | Jayamanne, Dasantha ; Back, Michael ; Wheeler, H.; Cook, R.; Teo, C.; Brazier, D.; Schembri, G.; Kastelan, M.; Guo, L. |
| 8 | | Jan-2021 | "SQiD, the Single Question in Delirium; can a single question help clinicians to detect delirium in hospitalised cancer patients?" running heading Single Question in Delirium" (Bcan-D-20-01665) | Buchanan, Angus M ; Sands, M.B.; Sharma, S.; Carpenter, L.; Hartshorn, A.; Lee, J.T.; Lujic, S.; Congdon, M.E.; Agar, M.; Vardy, J.L. |
| 9 | | May-2016 | Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma | Back, Michael ; Gzell, C.; Wheeler, H.; McCloud, P.; Kastelan, M. |
| 10 | | Mar-2017 | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma | Back, Michael ; Perry, J.R.; Laperriere, N.; O'Callaghan, C.J.; Brandes, A.A.; Menten, J.; Phillips, C.; Fay, M.; Nishikawa, R.; Cairncross, J.G.; Roa, W.; Osoba, D.; Rossiter, J.P.; Sahgal, A.; Hirte, H.; Laigle-Donadey, F.; Franceschi, E.; Chinot, O.; Golfinopoulos, V.; Fariselli, L.; Wick, A.; Feuvret, L.; Tills, M.; Winch, C.; Baumert, B.G.; Wick, W.; Ding, K.; Mason, W.P. |
| 11 | | Nov-2018 | The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors | Chang, Joe H ; Poon, I.; Erler, D.; Zhang, L.; Cheung, P. |
| 12 | | Mar-2020 | The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma | Wong, Matthew ; Jayamanne, Dasantha ; Back, Michael ; Chan, J.; Wheeler, H.; Khasraw, M.; Kastelan, M.; Guo, L. |
| 13 | | May-2019 | Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma | Cuncannon, Moire ; Wong, Matthew ; Jayamanne, Dasantha ; Cove, Nicola ; Back, Michael ; Guo, L.; Wheeler, H. |
| 14 | | Oct-2017 | Remote dosimetric auditing for intensity modulated radiotherapy: A pilot study | Zwan, Benjamin ; Miri, N.; Lehmann, J.; Legge, K.; Vial, P.; Greer, P.B. |
| 15 | | Jun-2019 | Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma | Jayamanne, Dasantha ; Wong, Matthew ; Back, Michael ; Back, E.; Kastelan, M.; Khasraw, M.; Brown, C.; Wheeler, H. |
| 16 | | Mar-2017 | Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma | Back, Michael ; Eade, Thomas ; LeMottee, Monica ; Crasta, C.; Wheeler, H.; Guo, L.; Bailey, D. |
| 17 | | 9-Jun-2021 | Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma | Cook, Theresa A ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, Nicola ; Back, Michael ; Wheeler, H.; Parkinson, J.; Cook, R. J.; Kastelan, M. A.; Brown, C. |
| 18 | | Jan-2017 | Radiotherapy in Glioblastoma: the past, the present and the future | Back, Michael ; Gzell, C.; Wheeler, H.; Bailey, D.; Foote, M. |
| 19 | | Nov-2018 | Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group | Lieng, Hester ; Eade, Thomas ; Kneebone, Andrew ; Hayden, A.J.; Christie, D.R.H.; Davis, B.J.; Emmett, L.; Holt, T.; Hruby, G.; Pryor, D.; Shakespeare, T.P.; Sidhom, M.; Skala, M.; Wiltshire, K.; Yaxley, J. |
| 20 | | Jun-2019 | Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group | Lieng, Hester ; Kneebone, Andrew ; Hayden, A.J.; Christie, D.R.H.; Davis, B.J.; Eade, Thomas ; Emmett, L.; Holt, T.; Hruby, G.; Pryor, D.; Sidhom, M.; Skala, M.; Yaxley, J.; Shakespeare, T.P. |
| 21 | | Sep-2018 | Radiation, inflammation and the immune response in cancer | Back, Michael ; Eade, Thomas ; McKelvey, K.J.; Hudson, A.L.; Diakos, C.I. |
| 22 | | Mar-2016 | Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma | Back, Michael ; Gzell, C.; Wheeler, H.; Huang, D.; Gaur, P.; Chen, J.; Kastelan, M. |
| 23 |  | Jul-2018 | Predicting patterns of failure in temporal lobe GBMs: Possible implications on radiotherapy treatment portals | Jayamanne, Dasantha ; Back, Michael ; Wheeler, H.; Brazier, D.; Newey, A.; Kastelan, M.; Guo, L. |
| 24 | | Oct-2020 | Platinum-containing regimens for triple-negative metastatic breast cancer | Chan, Matthew M K ; Egger, S.J.; Luo, Q.; Wilcken, N. |
| 25 | | Jun-2019 | Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: An Australian population-based study | Calopedos, Ross J S ; Ruthven, Stephen ; Bang, A.; Baade, P.D.; Yu, X.Q.; Patel, M.I.; Smith, D.P. |
| 26 | | Apr-2019 | Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation | Back, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Brazier, D.; Newey, A.; Bailey, D.; Schembri, G.; Hsiao, E.; Khasraw, M.; Kastelan, M.; Brown, C.; Wheeler, H. |
| 27 | | Sep-2016 | Oxidative stress in prostate cancer patients: A systematic review of case control studies | Back, Michael ; Eade, Thomas ; Oh, B.; Figtree, G.; Costa, D.; Hruby, G.; Lim, S.; Elfiky, A.; Martine, N.; Rosenthal, D.; Clarke, S. |
| 28 | | Oct-2018 | Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre | Back, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, N.; Wheeler, H.; Khasraw, M.; Guo, L.; Back, J. |
| 29 | | Sep-2017 | A novel and independent method for time-resolved gantry angle quality assurance for VMAT | Zwan, Benjamin ; Fuangrod, T.; Greer, P.B.; Barnes, M.P.; Lehman, J. |
| 30 | | Feb-2020 | Molecular and clonal evolution in recurrent metastatic gliosarcoma | Anderson, Kevin J; Tan, Aaron C; Parkinson, Jonathon; Back, Michael ; Kastelan, Marina; Newey, Allison; Brewer, Janice; Wheeler, Helen; Hudson, Amanda L; Amin, Samirkumar B; Johnson, Kevin C; Barthel, Floris P; Verhaak, Roel G W; Khasraw, Mustafa |
| 31 | | Mar-2017 | A method for evaluating treatment quality using in vivo EPID dosimetry and statistical process control in radiation therapy | Zwan, Benjamin ; Fuangrod, T.; Greer, P.B.; Simpson, J.; Middleton, R.H. |
| 32 | | May-2018 | Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma | Chan, Matthew M K ; Lee, J.H.J.; Lyle, M.; Menzies, A.M.; Lo, S.; Clements, A.; Cabral, N.L.; Kefford, R.F.; Long, G.V. |
| 33 | | Aug-2016 | Low Rate of Subsequent Whole Brain Radiotherapy Following a Policy of Local Therapy with MRI Surveillance for Central Nervous System Oligometastases | Harris, G.; Cook, R.; Teo, C.; Jayamanne, D.; Guo, L.; Back, Michael |
| 34 | | May-2020 | Levels of plasma cytokine in patients undergoing neoadjuvant androgen deprivation therapy and external beam radiation therapy for adenocarcinoma of the prostate | Thachil, Thanuja ; Singh, J.; Sohal, S.S.; Ahuja, K.; Lim, A.; Duncan, H.; De Ieso, P. |
| 35 | | Mar-2015 | Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma | Back, Michael ; Gzell, C.; Kastelan, M.; Guo, L.; Wheeler, H. |
| 36 | | Jan-2022 | Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy | Jayamanne, Dasantha ; Wong, Matthew ; Back, Michael ; Metz, G.; Wheeler, H.; Cook, R.; Little, N.; Parkinson, J.; Kastelan, M.; Brown, C. |
| 37 | | Jun-2021 | Junior Doctor Evaluation of Radiation Oncology Education and Training in Medical Schools and Prevocational Training in Australia | Windsor, Apsara ; Chelvarajah, R.; Nicholls, L.; Bravery, B.; Shi, K.; Turner, S.; Tieu, M.T. |
| 38 | | Aug-2016 | Investigation of a real-time EPID-based patient dose monitoring safety system using site-specific control limits | Zwan, Benjamin ; Fuangrod, T.; Greer, P.B.; Woodruff, H.C; Simpson, J.; Bhatia, S.; vanBeek, T.A.; McCurdy, B.M.; Middleton, R.H. |
| 39 | | Nov-2020 | Introducing Computed Tomography Simulation-Free and Electronic Patient-Reported Outcomes-Monitored Palliative Radiation Therapy into Routine Care: Clinical Outcomes and Implementation Experience | Back, Michael ; Schuler, T.; Hruby, G.; Carroll, S.; Jayamanne, Dasantha ; Kneebone, Andrew ; Stevens, M.; Lamoury, G.; Morgia, M.; Wong, S.; Grimberg, K.; Roderick, S.; Booth, J.; Eade, Thomas |
| 40 | | Dec-2020 | An Innovative Tai Chi and Qigong Telehealth Service in Supportive Cancer Care During the COVID-19 Pandemic and Beyond | Back, Michael ; Oh, B.; Van Der Saag, D.; Morgia, M.; Carroll, S.; Boyle, F.; Lamoury, G. |
| 41 | | Apr-2019 | Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management | Back, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Brazier, D.; Newey, A.; Bailey, D.; Schembri, G; Hsiao, E.; Khasraw, M.; Kastelan, M.; Guo, L.; Clarke, S.; Wheeler, H. |
| 42 | | 21-Oct-2022 | Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review | Yuile, Alexander; Satgunaseelan, Laveniya; Wei, Joe; Kastelan, Marina; Back, Michael F ; Lee, Maggie; Wei, Heng; Buckland, Michael E; Lee, Adrian; Wheeler, Helen R |
| 43 | | 1-May-2019 | Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033 | Dirven, Linda; Reijneveld, Jaap C; Taphoorn, Martin J B; Coens, Corneel; El-Badawy, Samy A; Tzuk-Shina, Tzahala; Bravo-Marques, Jose; Back, Michael ; Stalpers, Lukas J A; Stupp, Roger; Baumert, Brigitta G; Seidel, Clemens |
| 44 | | Dec-2020 | Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis | Back, Michael ; Wijetunga, A.; Jayamanne, Dasantha ; Cook, R.; Parkinson, J.; Little, N.; Curtis, J.; Brown, C. |
| 45 | | Nov-2016 | Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study | Back, Michael ; Reijneveld, J.C.; Taphoorn, M.J.; Coens, C.; Bromberg, J.E.; Mason, W.P.; Hoang-Xuan, K.; Ryan, G.; Hassel, M.B.; Enting, R.H.; Brandes, A.A.; Wick, A.; Chinot, O.; Reni, M.; Kantor, G.; Thiessen, B.; Klein, M.; Verner, E.; Borchers, C.; Hau, P.; Smits, A.; Golfinopoulos, V.; Gorlia, T.; Bottomley, A.; Stupp, R.; Baumert, B.G. |
| 46 | | Oct-2017 | Health and well-being benefits of spending time in forests: systematic review | Back, Michael ; Oh, B.; Lee, K.J.; Zaslawski, C.; Yeung, A.; Rosenthal, D.; Larkey, L. |
| 47 | | May-2021 | The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review | Back, Michael ; Eade, Thomas ; Kneebone, Andrew ; Oh, B.; Lamoury, G.; Carroll, S.; Morgia, M.; Hruby, G.; Stevens, M.; Boyle, F.; Clarke, S.; Corless, B.; Molloy, M.; Rosenthal, D. |
| 48 | | Oct-2020 | FROGG patterns of practice survey and consensus recommendations on radiation therapy for MIBC | Kneebone, Andrew ; Cardoso, M.; Choudhury, A.; Christie, D.; Eade, Thomas ; Foroudi, F.; Hayden, A.; Holt, T.; Sasso, G.; Shakespeare, T.P.; Sidhom, M. |
| 49 | | Apr-2019 | Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapy | Jayamanne, Dasantha ; Stevens, Mark ; Back, Michael ; Or, M.; Guo, L.; Parkinson, J.; Cook, R.; Little, N. |
| 50 | | Dec-2018 | FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot study | Back, Michael ; Jayamanne, Dasantha ; Chan, D.L.; Hsiao, E.; Schembri, G.; Bailey, D.; Roach, P.J.; Lee, A.; Ghasemzadeh, M.; Hayes, A.R.; Cook, R.; Parkinson, J.; Drummond, J.P.; Ibbett, I.; Wheeler, H. |
| 51 | | Apr-2017 | Factors affecting whether or not cancer patients consider using acupuncture | Back, Michael ; Eade, Thomas ; Oh, B.; Kneebone, Andrew ; Pavlakis, N.; Clarke, S.; Eslick, G.; River, J. |
| 52 | | Sep-2016 | An EPID-based system for gantry-resolved MLC quality assurance for VMAT | Zwan, Benjamin ; Barnes, M.P.; Fuangrod, T.; Stanton, C.J.; O'Connor, D.J.; Keall, P.J.; Greer, P.B. |
| 53 | | Jun-2018 | Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer Patients: Prospective Clinical Trial Results | Zwan, Benjamin ; Keall, P.J.; Colvill, E.; O'Brien, R.; Caillet, V.; Eade, Thomas ; Kneebone, Andrew ; Hruby, G.; Poulsen, P.R.; Greer, P.B.; Booth, J. |
| 54 | | 30-Jun-2020 | The Effects of Tai Chi and Qigong on Immune Responses: A Systematic Review and Meta-Analysis | Oh, Byeongsang; Bae, Kyeore; Lamoury, Gillian; Eade, Thomas ; Boyle, Frances; Corless, Brian; Clarke, Stephen; Yeung, Albert; Rosenthal, David; Schapira, Lidia; Back, Michael |
| 55 | | Dec-2020 | The Effects of Acupuncture on Cancer-Related Fatigue: Updated Systematic Review and Meta-Analysis | Jang, Andrew; Brown, Chris; Lamoury, Gillian; Morgia, Marita; Boyle, Frances; Marr, Isobel; Clarke, Stephen; Back, Michael ; Oh, Byeongsang |
| 56 | | Nov-2016 | The dosimetric impact of control point spacing for sliding gap MLC fields | Zwan, Benjamin ; Hindmarsh, Jonathan ; Seymour, Erin; Kandasamy, Kankean; Sloan, Kirbie; David, Rajesakar; Lee, Christopher |
| 57 | | Aug-2017 | Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring | Chan, Matthew M K ; Sabanathan, D.; Zhang, A.; Fox, P.; Coulter, S.; Gebski, V.; Balakrishnar, B.; Liddle, C.; Gurney, H. |
| 58 | | Jun-2018 | Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment | Back, Michael ; McKenzie, H.; Levy, D.; Pavlakis, N.; Oh, B. |
| 59 | | Jun-2021 | Concurrent carbogen and nicotinamide with radiation therapy in muscle invasive bladder cancer: A report on feasibility in the Australian setting | Anzela, Anzela ; Min, M.; Knesl, M.; Buddle, N.; Azzopardi, M.; Hooshmand, R.; Barrett, S.; Notman, A.; Woolls, H.; Wilson, J.; Vignarajah, D.D. |
| 60 | | Aug-2017 | Commissioning and quality assurance for VMAT delivery systems: An efficient time-resolved system using real-time EPID imaging | Zwan, Benjamin ; Hindmarsh, Jonathan ; Barnes, M.P.; Lim, S.B.; Lovelock, D.M.; Fuangrod, T.; O'Connor, D.J.; Keall, P.J.; Greer, P.B. |
| 61 | | Nov-2019 | Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis | Thachil, Thanuja ; Lamichhane, S.R.; Gee, H.; Milic, N. |
| 62 | | Aug-2017 | Breast interest group faculty of radiation oncology: Australian and New Zealand patterns of practice survey on breast radiotherapy | Nguyen, Kimberley ; Windsor, Apsara ; Mackenzie, P.; Allen, A.; Dreosti, M.; Morgia, M.; Zissiadis, Y.; Lamoury, G. |
| 63 | | Dec-2016 | Benchmarking clinical practice quality: an audit of ipsilateral breast tumor recurrence in patients managed for T1/T2 breast carcinoma | Back, Michael ; Suttie, C.; Donovan, J.; Holecek, M.; Morgia, M.; Guo, L.; Lamoury, G. |
| 64 | | 10-Nov-2023 | Association of MRI Volume Parameters in Predicting Patient Outcome at Time of Initial Diagnosis of Glioblastoma | Lau, Kin Sing; Ruisi, Isidoro; Back, Michael |
| 65 | | Aug-2019 | Adenoid Cystic Carcinoma of the Bartholin's Gland: A Diagnostic Dilemma | Leow, Jerome B Y ; Thachil, Thanuja ; Lo, C.C.W.; Naing, K.; Jaaback, K. |
| 66 | | Jun-2018 | Acupuncture in Oncology: The Effectiveness of Acupuncture May Not Depend on Needle Retention Duration | Eade, Thomas ; Kneebone, Andrew ; Back, Michael ; Oh, B.; Hruby, G.; Lamoury, G.; Pavlakis, N.; Clarke, S.; Zaslawski, C.; Marr, I.; Costa, D. |
| 67 | | Jun-2018 | Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions | Back, Michael ; Oh, B.; Yeung, A.; Klein, P.; Larkey, L.; Ee, C.; Zaslawski, C.; Knobf, T.; Payne, P.; Stener-Victorin, E.; Lee, R.; Choi, W.; Chun, M.; Bonucci, M.; Lang, H.D.; Pavlakis, N.; Boyle, F.; Clarke, S.; Yang, P.; Wei, Y.; Guo, X.; Weng, C.D.; Irwin, M.R.; Elfiky, A.; Rosenthal, D. |
